Raphael Pharmaceutical Inc. (RAPH)
OTCMKTS · Delayed Price · Currency is USD
0.2200
-0.1170 (-34.72%)
At close: Jun 5, 2025

Raphael Pharmaceutical Market Cap

Raphael Pharmaceutical has a market cap or net worth of $4.32 million as of June 18, 2025.

Market Cap
4.32M
Enterprise Value
4.31M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.22

Market Cap Chart

Since January 5, 2023, Raphael Pharmaceutical's market cap has decreased from 34.37M to 4.32M, a decrease of -87.44%. That is a compound annual growth rate of -57.62%.

History

DateMarket Cap% Change
Jun 5, 20254.32M-34.72%
May 27, 20256.61M52.01%
May 8, 20254.35M-77.12%
Feb 18, 202519.02M566.67%
Feb 13, 20252.85M-84.75%
Jan 10, 202518.70M33.33%
Jan 7, 202514.03M87.50%
Jan 3, 20257.48M53.85%
Oct 23, 20244.86M-84.24%
Jun 25, 202430.86M120.00%
Jun 24, 202414.03M-54.27%
May 31, 202430.67M6.72%
May 21, 202428.74M55.32%
Dec 20, 202318.50M-
Nov 30, 202318.50M70.35%
Nov 27, 202310.86M-35.32%
Aug 14, 202316.79M-38.57%
Jul 13, 202327.33M28.46%
Jul 6, 202321.28M-9.89%
Jun 21, 202323.61M1.38%
Jun 16, 202323.29M-30.95%
Jun 7, 202333.73M5.00%
May 25, 202332.13M-4.76%
May 23, 202333.73M5.00%
May 18, 202332.13M-0.82%
May 8, 202332.39M2.56%
May 3, 202331.58M-9.30%
May 2, 202334.82M0.38%
Apr 25, 202334.69M-
Apr 24, 202334.69M0.47%
Apr 20, 202334.53M4.39%
Apr 18, 202333.08M7.89%
Apr 17, 202330.66M0.53%
Apr 14, 202330.50M-0.53%
Apr 11, 202330.66M8.57%
Apr 6, 202328.24M-7.41%
Apr 5, 202330.50M19.32%
Apr 4, 202325.56M55.29%
Mar 31, 202316.46M-2.86%
Mar 21, 202316.94M-4.55%
Feb 7, 202317.75M-1.79%
Jan 31, 202318.07M0.90%
Jan 30, 202317.91M-8.26%
Jan 27, 202319.52M-51.60%
Jan 24, 202340.34M-
Jan 19, 202340.34M2.04%
Jan 18, 202339.53M-
Jan 17, 202339.53M15.01%
Jan 5, 202334.37M-

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Endo, Inc. 1.60B
Elite Pharmaceuticals 790.52M
Veradigm 747.25M
Nika Pharmaceuticals 708.22M
Tian'an Technology Group 637.25M
CytoDyn 437.04M
Glass House Brands 398.13M
Northwest Biotherapeutics 388.59M
Market Cap Rankings